ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 18 Feb 2013
Last Applicant/ Owned by
345 Park Avenue
New York
NY
10154
Serial Number
77657138 filed on 27th Jan 2009
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
POBRIVNA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, name Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Mark Details
Serial Number
No 77657138
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 19th Feb 2013 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 18th Feb 2013 | ABANDONMENT - NO USE STATEMENT FILED |
| 12th Jul 2012 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| 11th Jul 2012 | EXTENSION 5 GRANTED |
| 26th Jun 2012 | EXTENSION 5 FILED |
| 26th Jun 2012 | TEAS EXTENSION RECEIVED |
| 04th Jan 2012 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| 03rd Jan 2012 | EXTENSION 4 GRANTED |
| 21st Dec 2011 | EXTENSION 4 FILED |
| 21st Dec 2011 | TEAS EXTENSION RECEIVED |